Genome sequencing in the prenatal diagnosis of structural malformations in the fetus

Best Pract Res Clin Obstet Gynaecol. 2024 Dec:97:102539. doi: 10.1016/j.bpobgyn.2024.102539. Epub 2024 Sep 13.

Abstract

Prenatal genetic diagnosis has undergone two pivotal paradigm shifts, initially with the introduction of chromosomal microarray and subsequently with the advent of next-generation sequencing technologies (NGS). NGS technology has given rise to a multitude of applications, with gene panels, exome sequencing (ES), and genome sequencing (GS) emerging as highly promising tests for prenatal genetic investigations. These advanced approaches have demonstrated superior diagnostic rates when compared to conventional testing methods, showcasing the evolution and enhancement of prenatal genetic screening and diagnostic capabilities. With these ground-breaking innovations, NGS technologies have the potential to replace current standard practice in prenatal diagnosis. With the increasing use of prenatal sequencing, the need for better education and guidance on their applications grows. This chapter aims to illustrate the detection scope and feasibility of various NGS-based methods that are currently used in prenatal diagnosis.

Keywords: Exome sequencing; Fetal malformation; Genome sequencing; Low-pass genome sequencing; Prenatal diagnosis.

Publication types

  • Review

MeSH terms

  • Congenital Abnormalities / diagnosis
  • Congenital Abnormalities / genetics
  • Exome Sequencing / methods
  • Female
  • Genetic Testing / methods
  • High-Throughput Nucleotide Sequencing* / methods
  • Humans
  • Pregnancy
  • Prenatal Diagnosis* / methods
  • Whole Genome Sequencing